InflaRx (NASDAQ:IFRX – Free Report) had its target price hoisted by Guggenheim from $7.00 to $10.00 in a report published on Wednesday morning, Ratings reports. The brokerage currently has a buy ...

Recent landmark studies on the role of plasma exchange (PLEX), standardisation of glucocorticoid (GC) dosing, use of rituximab (RTX) for maintenance therapy, C5a receptor (C5aR)-targeted and ...

Allowing people with state-issued concealed carry licenses or permits to conceal a handgun in any other state, a bill ...

PitchBook, the premiere data provider for the private and public equity markets, today announced the winners of the 2024 PitchBook Lending League Table Awards. These rankings, part of PitchBook’s ...